Jump to content
Advertisement
Sign in to follow this  
Health Reporter

Pubmed-Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?

Recommended Posts

Health Reporter
Related Articles

Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?

Am J Gastroenterol. 2019 May 01;:

Authors: Shaukat A, Brenner DM

Abstract
Irritable bowel syndrome (IBS) is a common disorder of heterogeneous pathogenesis, and alterations in the gut microbiome/dysbiosis play a role in the development of symptoms in a subset of individuals with IBS. Consequently, it stands to reason that modulation of the microbiome via fecal microbial transplant (FMT) may serve as an effective treatment strategy because this has proven effective for treating other illnesses such as Clostridium difficile colitis. Small studies completed to date have offered conflicting results and the strains used, route of administration, and IBS subtypes may all play a role in treatment outcomes. A better understanding of the altered microbiome of patients with IBS and more rigorous trials are warranted before the utility of fecal microbial transplant for IBS symptoms can be determined.

PMID: 31082878 [PubMed - as supplied by publisher]

View the full article

Share this post


Link to post
Share on other sites
Advertisement
Sign in to follow this  

×
×
  • Create New...